Health Care & Life Sciences » Pharmaceuticals | Windtree Therapeutics Inc.

Windtree Therapeutics Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
86,283.00
44,711.00
38,722.00
5,588.00
1,815.00
25,146
Total Accounts Receivable
67.00
-
-
-
-
-
Inventories
112.00
27.00
-
-
-
-
Other Current Assets
777.00
821.00
2,072.00
1,606.00
422.00
507
Total Current Assets
87,239.00
45,559.00
40,794.00
7,194.00
2,237.00
25,653
Net Property, Plant & Equipment
1,656.00
1,637.00
1,039.00
1,054.00
885.00
802
Total Investments and Advances
325.00
225.00
225.00
225.00
225.00
171
Other Assets
97.00
78.00
2,319.00
1,226.00
-
-
Total Assets
89,317.00
47,499.00
44,377.00
9,699.00
3,347.00
315,378
ST Debt & Current Portion LT Debt
73.00
62.00
-
-
-
Accounts Payable
1,433.00
350.00
3,263.00
1,813.00
3,048.00
Other Current Liabilities
10,349.00
7,417.00
7,805.00
11,578.00
8,712.00
Total Current Liabilities
11,855.00
7,829.00
11,068.00
13,391.00
11,760.00
Long-Term Debt
18,423.00
20,302.00
25,000.00
25,000.00
15,000.00
Other Liabilities
538.00
169.00
43.00
138.00
507.00
Total Liabilities
30,816.00
28,300.00
36,111.00
38,529.00
27,267.00
Common Equity (Total)
58,501.00
19,199.00
8,266.00
28,830.00
23,920.00
Total Shareholders' Equity
58,501.00
19,199.00
8,266.00
28,830.00
23,920.00
Total Equity
58,501.00
19,199.00
8,266.00
28,830.00
23,920.00
Liabilities & Shareholders' Equity
89,317.00
47,499.00
44,377.00
9,699.00
3,347.00

About Windtree Therapeutics

View Profile
Address
2600 Kelly Road
Warrington Pennsylvania 18976
United States
Employees -
Website http://www.windtreetx.com
Updated 07/08/2019
Windtree Therapeutics, Inc. engages in the manufacture and development of products for infants and respiratory diseases. It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. The company was founded by Evan Myrianthopoulos and James S.